What medical device firms need to be aware of - benefits of compliance as well as the dangers of inadequate complaint handling.
FDA warning letters and recalls are posted on FDA’s website and published in trade magazines, newspapers available to firm’s competitors, and has even driven the firm’s stocks down. This presentation will review the regulations and point out some of the pitfalls in complaint handling and reporting.
Areas Covered in the Seminar:
- FDA’s Complaint Definition 820.3 (b)
- Complaint Documentation
- Part 803 - Medical Device Reporting
- Part 806 - Reports of Corrections & Removals
- Warning letters and other FDA Remedies
- Complaint Handling Pitfalls
Who Will Benefit:
Medical device firms need to be aware of the benefits of compliance as well as the dangers of inadequate complaint handling. This Web seminar will explain the regulatory process and in understandable terms. Some employees who wish to gain a better understanding include:
- Quality & Regulatory Professionals
- Manufacturing & Design Engineers
- Marketing Product Managers
Instructor Profile
John Chapman, BS, MBA, RAC has over 30 years medical device regulatory experience and over 10 years experience with the European Union’s medical device directive, 93/42/EEC. John has led two device companies to ISO quality system certification and CE marking. He has been performed regulatory due diligence on over a dozen acquisitions in the past 12 years, exposing him to numerous quality systems, including consent decrees as well as many notified bodies. He earned his regulatory affairs certification (RAC) in 1998 and was a contributing author to 2004 Fundamentals of EU Regulatory Affairs, RAPS, 2004. He co-founded a local RAPS chapter and has been a speaker at these meetings and the annual RAPS conference.
